Innovative Partnerships Enhance Non-Invasive Screening Methods in Jaundice Treatment Trend: A Crucial Influence on the Kernicterus Treatment Market's Transformation in 2025

What Is the Expected Size and Growth Rate of the Kernicterus Treatment Market?
The kernicterus treatment market will grow from $2.98 billion in 2024 to $3.06 billion in 2025, at a CAGR of 3.0%. The growth is attributed to improvements in neonatal care practices, greater awareness among healthcare professionals, government initiatives for maternal and child health, research funding, and clinical trials.

The kernicterus treatment market is projected to grow to $3.37 billion by 2029, expanding at a CAGR of 2.4%, fueled by medical education, government funding for neonatal health, and advancements in neonatal jaundice monitoring technologies and phototherapy devices, alongside a focus on home-based solutions.

What Factors Are Fueling Growth in the Kernicterus Treatment Market?
The prevalence of neonatal jaundice is driving the growth of the kernicterus treatment market. Neonatal jaundice, or jaundice in newborns, is a common condition marked by yellowing of the skin and eyes in babies. Kernicterus treatment, commonly used for neonatal jaundice, helps manage symptoms and provides supportive care. The treatment involves replacing the baby's blood with one that has a lower bilirubin level, improving the child's quality of life. For instance, reports from the National Library of Medicine in October 2023 indicate that around 60% of term infants and 80% of preterm infants experience jaundice in their first week of life. Additionally, around 10% of breastfed infants remain jaundiced by the time they are one month old. As a result, the high prevalence of neonatal jaundice is expected to drive growth in the kernicterus treatment market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13470&type=smp

Which Leading Companies Are Shaping the Growth of the Kernicterus Treatment Market?
Major companies operating in the kernicterus treatment market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca plc., Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Johnson and Johnson Private Limited, Baxter International Inc., Grifols S.A, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Alembic Pharmaceuticals Limited, Lupin Pharmaceuticals Inc., CSL Limited, Glenmark Pharmaceuticals Ltd., Cipla Inc., Torrent Pharmaceuticals Ltd., Octapharma Brasil Ltda, Kedrion S.p.A, Biotest AG, Wockhardt Ltd., Mylan N.V., Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., China Biologic Products Holdings Inc.

What Are the Major Trends Shaping the Kernicterus Treatment Market?
Leading institutions in the cornea treatment market are increasingly entering partnerships to expand their reach and strengthen their competitive position. For example, in July 2024, the UCL Department of Medical Physics and Biomedical Engineering, a UK-based research and education institution, partnered with UCL Hospitals, a UK-based medical center, to launch NeoSCB. This smartphone application is designed to detect severe jaundice in newborns by analyzing images of the sclera (the white part of the eye), providing a non-invasive screening method. This tool is particularly valuable in resource-limited regions where traditional jaundice screening devices are expensive. By quantifying scleral yellowness, the app correlates its measurements with bilirubin levels in the bloodstream. The application demonstrated high accuracy, successfully identifying 74 out of 79 newborns with severe jaundice, making it comparable to standard screening methods like transcutaneous bilirubinometers.

What Are the Key Segments of the Kernicterus Treatment Market?
The kernicterus treatment market covered in this report is segmented -

1) By Treatment: Phototherapy, Intravenous Immunoglobulins (IVIG), Blood Transfusion, Medication, Other Treatments
2) By Symptoms: Jaundice, Unusual Eye Movements, Vomiting, Fever, Poor Feeding, Apnoea, Irritability, Seizures, Sleepiness, Other Symptoms
3) By Dosage: Injection, Solution, Other Dosages
4) By End-Users: Clinic, Hospital, Other End-Users

Subsegments:
1) By Phototherapy: Conventional Phototherapy, Fiberoptic Phototherapy, LED Phototherapy
2) By Intravenous Immunoglobulins (IVIG): Standard IVIG Therapy, High-Dose IVIG Therapy
3) By Blood Transfusion: Exchange Transfusion, Simple Transfusion
4) By Medication: Bilirubin-Lowering Agents, Antioxidants, Neuroprotective Agents
5) By Other Treatments: Supportive Care, Nutritional Support, Adjunct Therapies

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report

Which Region Dominates the Kernicterus Treatment Market?
North America was the largest region in the kernicterus treatment market in 2024. The regions covered in the kernicterus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Kernicterus Treatment Global Market Report?

- Market Size Analysis: Analyze the Kernicterus Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Kernicterus Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Kernicterus Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Kernicterus Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13470

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.